DHG Pharmaceutical JSC (DHG) - Total Assets
Based on the latest financial reports, DHG Pharmaceutical JSC (DHG) holds total assets worth ₫5.01 Trillion VND (≈ $190.18 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
DHG Pharmaceutical JSC - Total Assets Trend (2019–2025)
This chart illustrates how DHG Pharmaceutical JSC's total assets have evolved over time, based on quarterly financial data. Also see DHG market cap for the company's overall valuation and market capitalisation.
DHG Pharmaceutical JSC - Asset Composition Analysis
Current Asset Composition (December 2025)
DHG Pharmaceutical JSC's total assets of ₫5.01 Trillion consist of 75.3% current assets and 24.8% non-current assets. Review DHG total debt and obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (VND) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₫0.00 | 2.5% |
| Accounts Receivable | ₫595.57 Billion | 11.5% |
| Inventory | ₫1.02 Trillion | 19.8% |
| Property, Plant & Equipment | ₫0.00 | 0.0% |
| Intangible Assets | ₫174.42 Billion | 3.4% |
| Goodwill | ₫0.00 | 0.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how DHG Pharmaceutical JSC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See DHG stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: DHG Pharmaceutical JSC's current assets represent 75.3% of total assets in 2025, a decrease from 75.6% in 2019.
- Cash Position: Cash and equivalents constituted 2.5% of total assets in 2025, up from 1.7% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 5.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 19.8% of total assets.
DHG Pharmaceutical JSC Competitors by Total Assets
Key competitors of DHG Pharmaceutical JSC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM
|
India | Rs443.12 Billion |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Beijing Tongrentang Co Ltd
SHG:600085
|
China | CN¥29.95 Billion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
|
Harbin Pharmaceutical Group Co Ltd
SHG:600664
|
China | CN¥14.08 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
DHG Pharmaceutical JSC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.47 | 2.55 | 3.38 |
| Quick Ratio | 1.66 | 1.89 | 2.50 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₫2.23 Trillion | ₫2.53 Trillion | ₫2.99 Trillion |
DHG Pharmaceutical JSC - Advanced Valuation Insights
This section examines the relationship between DHG Pharmaceutical JSC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.65 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -13.3% |
| Total Assets | ₫5.17 Trillion |
| Market Capitalization | $449.56 Million USD |
Valuation Analysis
Below Book Valuation: The market values DHG Pharmaceutical JSC's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: DHG Pharmaceutical JSC's assets decreased by 13.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for DHG Pharmaceutical JSC (2019–2025)
The table below shows the annual total assets of DHG Pharmaceutical JSC from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₫5.17 Trillion ≈ $196.27 Million |
-13.32% |
| 2024-12-31 | ₫5.96 Trillion ≈ $226.41 Million |
-2.47% |
| 2023-12-31 | ₫6.11 Trillion ≈ $232.16 Million |
+18.23% |
| 2022-12-31 | ₫5.17 Trillion ≈ $196.36 Million |
+11.92% |
| 2021-12-31 | ₫4.62 Trillion ≈ $175.44 Million |
+3.83% |
| 2020-12-31 | ₫4.45 Trillion ≈ $168.98 Million |
+7.25% |
| 2019-12-31 | ₫4.15 Trillion ≈ $157.55 Million |
-- |
About DHG Pharmaceutical JSC
DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, dermatology, and beauty care products. It also manufactures and … Read more